COVID-19医学重症监护病房与非COVID-19医学重症监护病房心脏骤停后的结局:倾向性评分匹配分析
该研究在俄亥俄州东北部克利夫兰诊所医疗系统比较COVID-19医学ICU院内心脏骤停(2020年3月至10月)与大流行前非COVID-19医学ICU院内心脏骤停(2014年1月至2018年12月)的复苏努力与结局,采用倾向性评分匹配创建可比组。共纳入516例患者(COVID-19组51例,非COVID-19组465例),92.1%(n=475)初始骤停心律为不可除颤心律。匹配前COVID-19组出院存活率更高(12/51,23.5% vs 59/465,12.7%,P=0.03);匹配后(40例 vs 200例)存活率差异不再显著(10/40,25% vs 42/200,21%,P=0.67),ICU或住院时间及出院时神经结局在匹配队列间亦无显著差异。作者结论强调COVID-19患者应接受无偏倚、不受限制的复苏措施。
要点
- 匹配前COVID-19医学ICU院内心脏骤停出院存活率高于非COVID-19队列(23.5% vs 12.7%,P=0.03)。
- 倾向性评分匹配后(COVID-19组40例 vs 非COVID-19组200例)出院存活率无显著差异(25% vs 21%,P=0.67)。
- 匹配队列间ICU住院时间、住院时间及存活者出院时神经结局均无显著差异。
- 92.1%(n=475)患者初始骤停心律为不可除颤心律。
- 作者认为COVID-19患者应接受无偏倚、不受限制的复苏措施,不应受到劝阻。
适用人群与场景
- 医学重症监护病房(MICU)院内心脏骤停(IHCA)患者:COVID-19队列为2020年3月至2020年10月,非COVID-19队列为2014年1月至2018年12月,均来自俄亥俄州东北部克利夫兰诊所医疗系统(CCHS)。
研究设计与关键结果
- 研究类型为倾向性评分匹配分析,共纳入516例患者,COVID-19 MICU IHCA队列51例,非COVID-19 MICU IHCA队列465例。
- 研究人群平均(SD)年龄60.9(16)岁,56%为男性;92.1%(n=475)患者初始骤停心律为不可除颤心律。
- ICU入院时,COVID-19队列平均APACHE III评分低于非COVID-19队列(70[32.9] vs 101.3[39.6],P<0.01)。
- 匹配前COVID-19队列出院存活率高于非COVID-19队列(12[23.5%] vs 59[12.7%],P=0.03)。
- 倾向性评分匹配后选出40例COVID-19患者和200例非COVID-19患者,基线特征、合并症和APACHE III评分均衡良好。
- 匹配后出院存活率差异不再显著(10[25%] vs 42[21%],P=0.67)。
- 匹配队列间ICU住院时间、住院时间及存活者出院时神经结局均无显著差异。
证据类型、等级与局限
- 证据类型:倾向性评分匹配分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,COVID-19患者应接受无偏倚、不受限制的复苏措施,不应受到任何劝阻。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To assess whether there were differences in resuscitation efforts and outcomes for medical intensive care unit (MICU) in-hospital cardiac arrest (IHCA) during the COVID-19 pandemic when compared to pre-pandemic.
METHODS: Comparing COVID-19 MICU-IHCA patients (03/2020 to 10/2020) to non-COVID-19 MICU IHCA (01/2014 to 12/2018) at Clevleand Clinic Health System (CCHS) of NE Ohio. Propensity score matching analysis (PSMA) was used to create comparable groups.
RESULTS: There were a total of 516 patients, 51 in COVID-19 MICU IHCA cohort and 465 in the non-COVID-19 MICU IHCA cohort. The mean (SD) age of the study population was 60.9 (16) years and 56% were males. In 92.1% (n = 475) patients, initial arrest rhythm was non-shockable. At the time of ICU admission, compared to the non-COVID-19 MICU-IHCA cohort, the COVID-19 MICU IHCA cohort had a lower mean APACHE III score (70 [32.9] vs 101.3 [39.6], P = <0.01). The COVID-19 cohort had a higher rate of survival to hospital discharge (12 [23.5%] vs 59 [12.7%], P = 0.03). Upon PSMA, the algorithm selected 40 COVID-19 patients and 200 non-COVID-19 patients. Imbalances in baseline characteristics, comorbidities, and APACHE III were well-balanced after matching. Survival rate after matching became non-significant; (10 [25%] vs 42 [21%], P = 0.67). Further, there were no significant differences in ICU or hospital length-of-stay or neurological outcomes at discharge for survivors in the two matched cohorts.
CONCLUSION: It is imperative that COVID-19 patients receive unbiased and unrestricted resuscitation measures, without any discouragement.
参考来源
- Bhardwaj A, Alwakeel M, Kirincich J, et al. Outcomes after cardiac arrest in Medical Intensive Care Unit: A propensity score matching analysis of COVID-19 MICU vs non COVID-19 MICU cardiac arrest. Resuscitation. 2023. PMID: 37390957. doi:10.1016/j.resuscitation.2023.109890
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。